Bionaut Labs has developed remote-controlled nano-robots (AKA "Bionauts") to precisely target and safely deliver medicine hard-to-treat conditions, beginning with diseases of the central nervous system like Parkinson's, Huntington's diseases and brainstem gliomas.

Los Angeles-based Bionaut Labs was founded in 2017 by robotics expert Michael Shpigelmacher, Aviad Maizels and Alex Shpunt and is currently in pre-clinical trials.